{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T20:02:40Z","timestamp":1772308960358,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81302826"],"award-info":[{"award-number":["81302826"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874324"],"award-info":[{"award-number":["81874324"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1608283"],"award-info":[{"award-number":["U1608283"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.intimp.2019.105833","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T05:46:58Z","timestamp":1566539218000},"page":"105833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Hepatoprotection of yangonin against hepatic fibrosis in mice via farnesoid X receptor activation"],"prefix":"10.1016","volume":"75","author":[{"given":"Xiaohui","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junqiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kexin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengyuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2019.105833_bb0005","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jcmgh.2017.04.007","article-title":"Epigenetics and liver fibrosis","volume":"4","author":"Moran-Salvador","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.intimp.2019.105833_bb0010","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3892\/ijo.2016.3627","article-title":"AMP-activated protein kinase activator, HL156A reduces thioacetamide-induced liver fibrosis in mice and inhibits the activation of cultured hepatic stellate cells and macrophages","volume":"49","author":"Lee","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.intimp.2019.105833_bb0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jhep.2018.02.015","article-title":"Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis","volume":"69","author":"Petta","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2019.105833_bb0020","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3748\/wjg.v25.i6.659","article-title":"Cancer risk in primary sclerosing cholangitis: epidemiology, prevention, and surveillance strategies","volume":"25","author":"Fung","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.intimp.2019.105833_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aal3694","article-title":"Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-beta","volume":"9","author":"Hart","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2019.105833_bb0030","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jnutbio.2011.08.004","article-title":"Curcumin protects against thioacetamide-induced hepatic fibrosis by attenuating the inflammatory response and inducing apoptosis of damaged hepatocytes","volume":"23","author":"Wang","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.intimp.2019.105833_bb0035","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jhep.2016.06.003","article-title":"Cartilage oligomeric matrix protein participates in the pathogenesis of liver fibrosis","volume":"65","author":"Magdaleno","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2019.105833_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0036-1597816","article-title":"Regression of liver fibrosis","volume":"37","author":"Campana","year":"2017","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.intimp.2019.105833_bb0045","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/hep.29371","article-title":"Beta-catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis","volume":"67","author":"Thompson","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2019.105833_bb0050","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1053\/j.gastro.2004.08.001","article-title":"The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis","volume":"127","author":"Fiorucci","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2019.105833_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2018.00410","article-title":"Progression and regression of hepatic lesions in a mouse model of NASH induced by dietary intervention and its implications in pharmacotherapy","volume":"9","author":"Ding","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2019.105833_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33070-1","article-title":"FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis","volume":"8","author":"van Golen","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2019.105833_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/srep33453","article-title":"FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis","volume":"6","author":"Verbeke","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2019.105833_bb0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.taap.2016.11.006","article-title":"Obeticholic acid protects against carbon tetrachloride-induced acute liver injury and inflammation","volume":"314","author":"Zhang","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.intimp.2019.105833_bb0075","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.phrs.2012.04.003","article-title":"Kavalactones and the endocannabinoid system: the plant-derived yangonin is a novel CB(1) receptor ligand","volume":"66","author":"Ligresti","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2019.105833_bb0080","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1007\/s13197-013-1047-2","article-title":"Kavalactone content and chemotype of kava beverages prepared from roots and rhizomes of Isa and Mahakea varieties and extraction efficiency of kavalactones using different solvents","volume":"52","author":"Wang","year":"2015","journal-title":"J. Food Sci. Technol."},{"key":"10.1016\/j.intimp.2019.105833_bb0085","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.taap.2018.04.015","article-title":"Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro","volume":"348","author":"Gao","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.intimp.2019.105833_bb0090","doi-asserted-by":"crossref","first-page":"408","DOI":"10.7555\/JBR.31.20160160","article-title":"Kavalactone yangonin induces autophagy and sensitizes bladder cancer cells to flavokawain A and docetaxel via inhibition of the mTOR pathway","volume":"31","author":"Liu","year":"2017","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.intimp.2019.105833_bb0095","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1124\/mol.107.042499","article-title":"Kavalactones protect neural cells against amyloid beta peptide-induced neurotoxicity via extracellular signal-regulated kinase 1\/2-dependent nuclear factor erythroid 2-related factor 2 activation","volume":"73","author":"Wruck","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.intimp.2019.105833_bb0100","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2018.02.002","article-title":"Protective effects of yangonin from an edible botanical Kava against lithocholic acid-induced cholestasis and hepatotoxicity","volume":"824","author":"Kong","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2019.105833_bb0105","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12906-015-0916-9","article-title":"Protective effects of extracts from pomegranate peels and seeds on liver fibrosis induced by carbon tetrachloride in rats","volume":"15","author":"Wei","year":"2015","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.intimp.2019.105833_bb0110","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.2174\/092986712803341520","article-title":"Role of oxidative stress and molecular changes in liver fibrosis: a review","volume":"19","author":"Sanchez-Valle","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.intimp.2019.105833_bb0115","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.matbio.2018.04.006","article-title":"Liver fibrosis: direct antifibrotic agents and targeted therapies","volume":"69","author":"Schuppan","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.intimp.2019.105833_bb0120","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1478-3231.2007.01453.x","article-title":"Prevention of liver cirrhosis in rats by curcumin","volume":"27","author":"Bruck","year":"2007","journal-title":"Liver Int."},{"key":"10.1016\/j.intimp.2019.105833_bb0125","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0168-8278(01)00290-2","article-title":"Pyrrolidine dithiocarbamate protects against thioacetamide-induced fulminant hepatic failure in rats","volume":"36","author":"Bruck","year":"2002","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2019.105833_bb0130","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1039\/C8FO00107C","article-title":"Hepatoprotection of auraptene from peels of citrus fruits against thioacetamide-induced hepatic fibrosis in mice by activating farnesoid X receptor","volume":"9","author":"Gao","year":"2018","journal-title":"Food Funct."},{"key":"10.1016\/j.intimp.2019.105833_bb0135","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/hep.24148","article-title":"Nuclear receptors in liver disease","volume":"53","author":"Wagner","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2019.105833_bb0140","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/j.gastro.2014.12.005","article-title":"Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid","volume":"148","author":"Hirschfield","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2019.105833_bb0145","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jhep.2009.03.025","article-title":"Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis","volume":"51","author":"Zhang","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2019.105833_bb0150","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1524-475X.2009.00466.x","article-title":"Interactions between extracellular matrix and growth factors in wound healing","volume":"17","author":"Schultz","year":"2009","journal-title":"Wound Repair Regen."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919314559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919314559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:43:27Z","timestamp":1762551807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919314559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":30,"alternative-id":["S1567576919314559"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.105833","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatoprotection of yangonin against hepatic fibrosis in mice via farnesoid X receptor activation","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.105833","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105833"}}